Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Epidemiological Characteristics of Leprosy in China, 2018

Wang L, Sun P, Yu M, et al. Ovid Technologies (Wolters Kluwer Health). International Journal of Dermatology and Venereology. 2020; 3 (1) : 27-30.
Download PDF
Publication

Epidemiological features of leprosy in China, 2020

Jia-Yi P, Sun P, Wang L, et al. Ovid Technologies (Wolters Kluwer Health). International Journal of Dermatology and Venereology. 2022;
Download PDF
Publication

Leprosy Update in China, 2019

Wang L, Sun P, Yu M, et al. Ovid Technologies (Wolters Kluwer Health). International Journal of Dermatology and Venereology. 2022; 5 (1) : 15-19.
Download PDF
Publication

Incidencia de lepra en el municipio santa cruz del sur, Cuba. treinta años de estudio

Delgado RME, Curra Buitrago IC, Bárzaga IO, et al. Revista de leprología. 2022; 33 (3) : 171-186.
Publication

Dengue como enfermedad asociada causante de debut de lepra en estado reaccional. Presentación de un caso

García YGM, Fernández BM, Mouriño CNA, et al. Revista de leprología. 2022; 33 (3) : 187-195.
Publication

Ventajas de administrar dosis altas de clofazimina

Butlin CR, Maghanoy AA. Revista de leprología. 2022; 92 (4) : 427-432.
Publication

Prevalencia y factores de riesgo para discapacidades de grado 2 entre los niños y adolescentes recién diagnosticados de lepra: un análisis basado en las historias clínicas de la India

Upputuri B, Vulchi N, Singh R, et al. Revista de leprología. 2022; 93 (1) : 79-88.
Publication

Implementation of India’s National Active Case Detection and Regular Surveillance requires a reliable baseline

Pilaka K, Singh RK, Singh A, et al. Lepra. Leprosy Review. 2022; 93 (2) : 172-174.
Download PDF
Publication

Right to health and Hansen’s disease: the voice of girls and women affected by Hansen’s disease

Brandão PS, Duarte NIG, Soares PG, et al. Lepra. Leprosy Review. 2022; 93 (2) : 161-165.
Download PDF
Publication

Correction of ulnar claw hand – A comparative study of extensor carpi radialis longus (ECRL) and flexor digitorum superficialis (FDS) as the motor unit of choice

Sajid I, Ahmad S. Lepra. Leprosy Review. 2022; 93 (2) : 102-114.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 198
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD